CARL· Health Care› Health Information Services

Carlsmed, Inc.

Stage 2 · Advancing · week 10

As of Oct 22, 2026, Carlsmed is in Stage 2, the uptrend phase, now in week 10 (since Aug 17, 2026). It closed at $14.61, 14.0% below its 52-week high and above its 200-day average, which is rising.

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. More about the company

$14.61

+2.10% today

$399M · Small cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 16 in Health Information Services · #1 of 272 in Health Care

Is CARL early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2025-07-23 → 2026-10-22

S? 41w

S1 9w

S2 10w

2025-07-232026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 41w → S4 5w → S1 9w → S2 10w current

Total tracked: 65 weeks across 4 stage runs.

CARL among Health Information Services13th of 41 by relative strength

All 41 →

Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	AMWLAmerican Well Corporation Class A	Stage 2 · wk 25	97	+7.4%
2	HNGEHinge Health, Inc. Class A	Stage 2 · wk 20	96	+19.1%
3	BTSGBrightSpring Health Services, Inc.	Stage 3 · wk 8	94	+9.1%
4	NRCNRC Health	Stage 3 · wk 4	93	−0.1%
5	SOPHSOPHiA GENETICS SA	Stage 2 · wk 24	91	−12.7%
6	HTFLHeartflow, Inc.	Stage 2 · wk 10	87	+17.0%
7	HSTMHealthStream, Inc.	Stage 2 · wk 17	77	+20.3%
8	OMCLOmnicell, Inc.	Stage 4 · wk 10	70	+12.5%
…13	CARLCarlsmed, Inc.	Stage 2 · wk 10	57	−1.0%

vs 52W High

-14.0%

$8.83 lo$16.99 hi

14.0% below 52W high, pullback range

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 10

1w13w26w

Week 10, early Stage 2

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

18.3%

200 DMA: $12.35 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.52x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-1.0%

+35.3%

+44.9%

YTD

+25.6%

+3.6%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S2

Wk 10 · Vol 0.52x

2026-10-21S2

Wk 10 · Vol 1.08x

2026-10-20S2

Wk 10 · Vol 0.48x

2026-10-19S2

Wk 9 · Vol 0.52x

2026-10-16S2

Wk 9 · Vol 0.64x

2026-10-15S2

Wk 9 · Vol 0.29x

2026-10-14S2

Wk 9 · Vol 0.44x

2026-10-13S2

Wk 9 · Vol 0.40x

2026-10-12S2

Wk 8 · Vol 0.30x

2026-10-09S2

Wk 8 · Vol 0.52x

2026-10-08S2

Wk 8 · Vol 0.50x

2026-10-07S2

Wk 8 · Vol 0.41x

Moving averages & range

50 DMA

$14.99

200 DMA

$12.35

52W High

$16.99

52W Low

$8.83

5D Low

$13.41

Resistance levels (recent highs)

20d High

$15.30

60d High

$16.88

120d High

$16.88

250d High

$16.99

Next resistance

+4.7%

to 20d High

ROE

-66.1%

Profit margin -57.4%

Dividend Yield

0.00%

P/B 4.7

Carlsmed: quick answers

What stage is Carlsmed in?

As of Oct 22, 2026, Carlsmed (CARL) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 17, 2026 and is in week 10. What the four stages mean

Is Carlsmed in an uptrend?

Yes. Carlsmed is in a Stage 2 uptrend. It trades 18.3% above its 200-day average, which is rising.

How far is Carlsmed from its 52-week high?

Carlsmed closed at $14.61 on Oct 22, 2026, 14.0% below its 52-week high of $16.99. Its 52-week low is $8.83.

How has Carlsmed performed over the past year?

As of Oct 22, 2026, Carlsmed is up 3.6% over the past year and up 25.6% so far in 2026.

Which sector and industry is Carlsmed in?

Carlsmed is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.